Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

METABOLISM AND DISPOSITION OF IMATINIB MESYLATE IN HEALTHY VOLUNTEERS

Hans-Peter Gschwind, Ulrike Pfaar, Felix Waldmeier, Markus Zollinger, Claudia Sayer, Peter Zbinden, Michael Hayes, Rolf Pokorny, Michael Seiberling, Monique Ben-Am, Bin Peng and Gerhard Gross
Drug Metabolism and Disposition October 2005, 33 (10) 1503-1512; DOI: https://doi.org/10.1124/dmd.105.004283
Hans-Peter Gschwind
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulrike Pfaar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Felix Waldmeier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Zollinger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Sayer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Zbinden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Hayes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rolf Pokorny
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Seiberling
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Monique Ben-Am
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bin Peng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerhard Gross
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 33 no. 10 1503-1512
DOI 
https://doi.org/10.1124/dmd.105.004283
PubMed 
16006570

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received February 22, 2005
  • Accepted July 6, 2005
  • Published online September 15, 2005.

Article Versions

  • Earlier version (July 8, 2005 - 09:30).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Hans-Peter Gschwind,
  2. Ulrike Pfaar,
  3. Felix Waldmeier,
  4. Markus Zollinger,
  5. Claudia Sayer,
  6. Peter Zbinden,
  7. Michael Hayes,
  8. Rolf Pokorny,
  9. Michael Seiberling,
  10. Monique Ben-Am,
  11. Bin Peng and
  12. Gerhard Gross
  1. Novartis Pharma AG, Exploratory Development/Drug Metabolism & Pharmacokinetics, Basel, Switzerland (H.-P.G., U.P., F.W., M.Z., C.S., P.Z., G.G.); Novartis Pharmaceuticals Corporation, Exploratory Development/Bioanalytics & Pharmacokinetics (M.H.), Clinical Pharmacology Oncology (M.B.-A., B.P.), East Hanover, New Jersey; and Swiss Pharma Contract, Clinical Pharmacology & Clinical Research, Allschwil, Switzerland (R.P., M.S.)
  1. Address correspondence to:
    Dr. Hans-Peter Gschwind, Exploratory Development/DMPK, Novartis Pharma AG, WKL-135.2.25, CH-4002 Basel, Switzerland. E-mail: hans-peter.gschwind{at}novartis.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: July 2005 to January 2021

AbstractFullPdf
Jul 2005470166
Aug 200525071
Sep 200512559170
Oct 200572120103
Nov 2005437561
Dec 2005343522
Jan 2006512027
Feb 2006362531
Mar 2006361921
Apr 2006272029
May 2006313325
Jun 2006301925
Jul 2006231016
Aug 2006362324
Sep 2006281513
Oct 2006285944
Nov 20064210879
Dec 2006295442
Jan 2007197165
Feb 2007287152
Mar 2007249565
Apr 2007286446
May 2007144546
Jun 2007175155
Jul 2007176254
Aug 2007305135
Sep 2007225647
Oct 2007205642
Nov 2007174460
Dec 2007133329
Jan 2008246842
Feb 2008164241
Mar 2008186053
Apr 2008265647
May 2008235661
Jun 2008214651
Jul 2008547872
Aug 2008254141
Sep 2008409585
Oct 2008206357
Nov 2008224148
Dec 2008163340
Jan 2009245862
Feb 2009266746
Mar 20094110363
Apr 2009568259
May 2009626047
Jun 2009474053
Jul 2009804942
Aug 2009664231
Sep 2009604957
Oct 2009516562
Nov 2009583442
Dec 2009583350
Jan 2010704447
Feb 2010794556
Mar 2010927771
Apr 2010636039
May 2010294929
Jun 2010738350
Jul 2010919352
Aug 2010586246
Sep 2010547451
Oct 2010607355
Nov 2010638254
Dec 2010355647
Jan 2011407243
Feb 2011474740
Mar 2011386861
Apr 2011525788
May 2011334869
Jun 2011524359
Jul 2011675369
Aug 201111912084
Sep 201118015995
Oct 2011191183103
Nov 2011163173106
Dec 2011131194108
Jan 2012180189109
Feb 201226017185
Mar 2012354175106
Apr 2012330216121
May 2012588233123
Jun 2012687209105
Jul 2012973530115
Aug 2012910497134
Sep 2012995590184
Oct 2012154105103
Nov 2012189152118
Dec 20128612275
Jan 2013121131121
Feb 201310513581
Mar 2013117131106
Apr 201312514390
May 2013103146103
Jun 2013475781
Jul 2013498084
Aug 2013375584
Sep 2013636676
Oct 2013498084
Nov 2013515899
Dec 2013355382
Jan 2014486570
Feb 2014494375
Mar 2014658384
Apr 20145383114
May 2014556587
Jun 2014385382
Jul 2014345654
Aug 2014273827
Sep 2014364261
Oct 2014413053
Nov 2014435946
Dec 2014205243
Jan 2015264640
Feb 2015435656
Mar 2015487459
Apr 2015439167
May 2015407587
Jun 2015226372
Jul 2015308852
Aug 2015328840
Sep 2015294749
Oct 2015359159
Nov 2015223153
Dec 2015285054
Jan 2016476157
Feb 2016375038
Mar 2016325056
Apr 2016398854
May 2016265261
Jun 2016234365
Jul 2016305284
Aug 2016313959
Sep 2016323269
Oct 2016218459
Nov 201613107102
Dec 201697456
Jan 201789145
Feb 201747628
Mar 201738530
Apr 2017116639
May 2017106059
Jun 2017114934
Jul 201794351
Aug 201796054
Sep 201776143
Oct 20171610446
Nov 2017138650
Dec 2017113944
Jan 2018164444
Feb 201877751
Mar 201876349
Apr 2018912282
May 201858993
Jun 201846357
Jul 201865055
Aug 201865050
Sep 201825230
Oct 201869156
Nov 201887557
Dec 2018821827
Jan 201986521
Feb 20191191124
Mar 20191011513
Apr 20191441213
May 20191151118
Jun 201958814
Jul 20198259
Aug 2019931124
Sep 201995711
Oct 20191182319
Nov 20199226
Dec 20198436
Jan 202010199
Feb 20208752
Mar 20201231014
Apr 20208469
May 20205965
Jun 2020661016
Jul 20207942
Aug 20205332
Sep 20203255
Oct 20206669
Nov 202063513
Dec 20207864
Jan 20216374

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 33 (10)
Drug Metabolism and Disposition
Vol. 33, Issue 10
1 Oct 2005
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
METABOLISM AND DISPOSITION OF IMATINIB MESYLATE IN HEALTHY VOLUNTEERS
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

METABOLISM AND DISPOSITION OF IMATINIB MESYLATE IN HEALTHY VOLUNTEERS

Hans-Peter Gschwind, Ulrike Pfaar, Felix Waldmeier, Markus Zollinger, Claudia Sayer, Peter Zbinden, Michael Hayes, Rolf Pokorny, Michael Seiberling, Monique Ben-Am, Bin Peng and Gerhard Gross
Drug Metabolism and Disposition October 1, 2005, 33 (10) 1503-1512; DOI: https://doi.org/10.1124/dmd.105.004283

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

METABOLISM AND DISPOSITION OF IMATINIB MESYLATE IN HEALTHY VOLUNTEERS

Hans-Peter Gschwind, Ulrike Pfaar, Felix Waldmeier, Markus Zollinger, Claudia Sayer, Peter Zbinden, Michael Hayes, Rolf Pokorny, Michael Seiberling, Monique Ben-Am, Bin Peng and Gerhard Gross
Drug Metabolism and Disposition October 1, 2005, 33 (10) 1503-1512; DOI: https://doi.org/10.1124/dmd.105.004283
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Candesartan glucuronide serves as a CYP2C8 inhibitor
  • Role of AADAC on eslicarbazepine acetate hydrolysis
  • Gene expression profile of human intestinal epithelial cells
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics